Use of Rapamycin in a Patient With Juvenile Myelomonocytic Leukemia: A Case Report

The relapse rate for children with juvenile myelomonocytic leukemia (JMML) status post hematopoietic stem cell transplantation (HSCT) approaches 50% within 5 years. Graft-versus-leukemia (GVL) is thought to play important role in the treatment of JMML. For this reason, careful management of immunosu...

Descripción completa

Detalles Bibliográficos
Autores principales: Upadhyay, Shivani Y., De Oliveira, Satiro N., Moore, Theodore B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593212/
https://www.ncbi.nlm.nih.gov/pubmed/28959694
http://dx.doi.org/10.1177/2324709617728528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593212/
https://www.ncbi.nlm.nih.gov/pubmed/28959694
http://dx.doi.org/10.1177/2324709617728528

Ejemplares similares